Bio-Path Holdings, Inc.
BPTH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $3 | $3 |
| - Cash | $0 | $0 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $0 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 50% | – |
| EBITDA | -$5 | -$3 | -$3 | -$3 |
| % Margin | – | – | -1,631.6% | – |
| Net Income | -$5 | -$3 | -$3 | -$2 |
| % Margin | – | – | -1,742.4% | – |
| EPS Diluted | -0.55 | -0.4 | -1.15 | -0.7 |
| % Growth | -37.5% | 65.2% | -64.3% | – |
| Operating Cash Flow | -$0 | -$1 | -$3 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$1 | -$3 | -$3 |